Scott L. Burrows, Chief Financial Officer at Arcutis Biotherapeutics, Inc. (ARQT), sold 25,120 shares at $20.07 ($504K) on 2021-12-27, disclosed to the SEC on 2021-12-28.
Open-market sale of $504k ARQT by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.07 | 12,560 | $252K | 50.0% |
| 2 | $20.07 | 12,560 | $252K | 50.0% |
| Total | $20.07 avg | 25,120 | $504K | 100% |
| Filing → |
| SYRE | SELL | 2026-08-05 | $717K | — | Filing → |
| SYRE | SELL | 2026-07-02 | $658K | — | Filing → |
| SYRE | SELL | 2026-06-26 | $1.3M | — | Filing → |